BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33830701)

  • 1. [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions].
    Fallet B; Miauton A; Comte D; Ribi C; Muller YD
    Rev Med Suisse; 2021 Apr; 17(733):690-696. PubMed ID: 33830701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allergic reactions to COVID-19 vaccines].
    Geersing TH; Tempels-Pavlica Ž; Borgsteede SD
    Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2.
    Caffarelli C; Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Paglialunga C; Saretta F; Mori F
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):58-60. PubMed ID: 35080320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
    Lindgren AL; Austin AH; Welsh KM
    J Prim Care Community Health; 2021; 12():21501327211024431. PubMed ID: 34120504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives.
    Sampath V; Rabinowitz G; Shah M; Jain S; Diamant Z; Jesenak M; Rabin R; Vieths S; Agache I; Akdis M; Barber D; Breiteneder H; Chinthrajah S; Chivato T; Collins W; Eiwegger T; Fast K; Fokkens W; O'Hehir RE; Ollert M; O'Mahony L; Palomares O; Pfaar O; Riggioni C; Shamji MH; Sokolowska M; Jose Torres M; Traidl-Hoffmann C; van Zelm M; Wang Y; Zhang L; Akdis CA; Nadeau KC
    Allergy; 2021 Jun; 76(6):1640-1660. PubMed ID: 33811364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Klimek L; Chaker AM; Cuevas M
    Laryngorhinootologie; 2021 Apr; 100(4):252-258. PubMed ID: 33524996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.
    Klimek L; Jutel M; Akdis CA; Bousquet J; Akdis M; Torres MJ; Agache I; Canonica GW; Del Giacco S; O'Mahony L; Shamji MH; Schwarze J; Untersmayr E; Ring J; Bedbrook A; Worm M; Zuberbier T; Knol E; Hoffmann-Sommergruber K; Chivato T
    Allergy; 2021 Jun; 76(6):1624-1628. PubMed ID: 33378789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination in our transplant recipients: The time is now.
    Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
    J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity Reactions to Vaccines: Current Evidence and Standards for SARS-CoV-2 Vaccines.
    Carvalho JC; Cunha F; Coutinho IA; Loureiro C; Faria E; Bom AT
    Acta Med Port; 2021 Jun; 34(7-8):541-547. PubMed ID: 34851819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later.
    Copaescu AM; Rosa Duque JS; Phillips EJ
    Ann Allergy Asthma Immunol; 2022 Jul; 129(1):40-51. PubMed ID: 35390476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
    Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations were made for diagnosis and management of allergic reactions to COVID-19 vaccines.
    Maki DG
    Ann Intern Med; 2021 Nov; 174(11):JC122. PubMed ID: 34724408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targets and strategies for vaccine development against SARS-CoV-2.
    Malik JA; Mulla AH; Farooqi T; Pottoo FH; Anwar S; Rengasamy KRR
    Biomed Pharmacother; 2021 May; 137():111254. PubMed ID: 33550049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.